跳至主要内容
临床试验/NCT06133322
NCT06133322招募中不适用

Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities

Tulane University2 个研究点 分布在 1 个国家目标入组 1,176 人开始时间: 2023年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,176
试验地点
2
主要终点
Implementation fidelity summary score

研究概览

简要总结

The burden of hypertension and related cardiovascular diseases, stroke, and end-stage kidney disease is disproportionately high in Black populations, especially in the South. The Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED) cluster randomized trial aims to test the effectiveness, implementation, and sustainability of a community health worker (CHW)-led multifaceted intervention compared to enhanced usual care for hypertension control in Black communities. In the BLESSED trial, the investigators plan to recruit 1,176 adults with hypertension (approximately 28 per church) from 42 predominantly Black churches in the Greater New Orleans area. The multifaceted intervention will last for 18 months, followed by a post-intervention follow-up visit at 24 months. The BLESSED trial aims to generate evidence regarding the effectiveness, implementation, and sustainability of this CHW-led church-based multifaceted intervention in eliminating hypertension disparities in the United States (US) general population.

详细描述

Louisiana residents, especially African Americans, bear a disproportionately high burden of hypertension and cardiovascular disease (CVD). In the Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED) cluster randomized trial, the investigators will compare the impact of two implementation strategies - a CHW-led multifaceted strategy and a group-based education strategy - for delivering interventions recommended by the 2017 American College of Cardiology (ACC) and the American Heart Association (AHA) hypertension clinical guidelines on implementation and clinical effectiveness outcomes in predominantly Black community members over 18 months. The BLESSED study utilizes an effectiveness-implementation hybrid design to: (1). test the effectiveness of a CHW-led church-based multifaceted implementation strategy for reducing estimated CVD risk over 18 months among African American church community members at high risk for CVD, and (2). assess the implementation outcomes (acceptability, adaptation, adoption, feasibility, fidelity, penetrance, cost-effectiveness, and sustainability) simultaneously. The Exploration, Preparation, Implementation, Sustainment (EPIS) framework has guided the development and evaluation of the multifaceted implementation strategy, which includes CHW-led health coaching on lifestyle changes and medication adherence; healthcare delivery in community; church-based exercise and weight loss programs; self-monitoring of blood pressure (BP); and provider education and engagement. The CHW-led church-based intervention will provide strong social support and tackle multiple social determinants of CVD disparities. The primary clinical effectiveness outcome is the difference in mean change of systolic blood pressure (SBP) from baseline to 18 months between intervention and control groups. The primary implementation outcome is a fidelity summary score for key implementation strategy components to the CHW-led church-based multifaceted implementation strategy assessed at the participant levels. This study has 90% statistical power to detect group differences in mean SBP change of 5.8 mm Hg over 18 months using a 2-sided significance level of 0.05. The investigators will recruit 1,176 participants (28 per church) who are aged ≥18 years with systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mm Hg, and randomly assign 21 churches to intervention and 21 to control; the investigators will implement the multifaceted intervention program; the investigators will follow-up participants and collect data on effectiveness and implementation outcomes at 6, 12, and 18 months; the investigators will evaluate the sustainability of the intervention at 6 months post-intervention; and the investigators will perform intention-to-treat analyses and disseminate and scale-up the proven-effective implementation strategy. The proposed study will generate evidence on the effectiveness, implementation, and sustainability of the multifaceted intervention aimed at eliminating CVD disparities in African American populations in the US.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

盲法说明

Clinical research coordinators and laboratory technicians who assess health-related outcomes will be blinded to intervention assignment. Study physicians who review serious adverse events and unanticipated problems will also be blinded to intervention assignment.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women aged ≥18 years
  • Community members associated with the participating churches (church members and their families and friends)
  • Systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mm Hg
  • Willing and able to participate in the intervention.
  • Willing and able to sign written informed consent.

排除标准

  • Prior hospitalization in the last 3 months for chronic heart failure or heart attack
  • Current diagnosis of cancer requiring chemotherapy or radiation therapy
  • Stage-5 chronic kidney disease requiring chronic dialysis or transplant
  • Pregnant or planning to become pregnant in the next 18 months
  • Planning to move out of the Greater New Orleans area during the next year

结局指标

主要结局

Implementation fidelity summary score

时间窗: Measured at 6, 12, and 18 months

The fidelity summary score is composed of the following key implementation strategy components: proportion of assigned health education sessions attended in all participants, proportion of assigned discussion sessions attended in all participants, proportion of recommended minutes of physical activity completed in all participants, proportion of days per week that fruits/vegetables are eaten as recommended in all participants, proportion of recommended home blood pressure (BP) monitoring completed in patients with hypertension, proportion of required provider visits attended in all patients, and proportion of antihypertensive medications taken in patients with hypertension. The score ranged from zero to six with a higher score indicates greater fidelity.

Difference in mean change of systolic blood pressure

时间窗: Measured from baseline to 18 months

Difference in mean change of systolic blood pressure from baseline to 18 months between intervention and control groups

次要结局

  • Difference in mean change of diastolic BP(Measured from baseline to 18 months)
  • Cost-effectiveness(Measured from baseline to 18 months)
  • Adoption (Churches)(Measured from baseline to 18 months)
  • Adoption (Providers)(Measured from baseline to 18 months)
  • Appropriateness(Measured from baseline to 18 months)
  • Feasibility to participant, community health worker, provider and churches(Measured from baseline to 18 months)
  • Fidelity of Group Health Education Session(Measured at 6, 12, and 18 months)
  • Nutrition Education Session Fidelity (community health worker-led strategy group)(Measured at 6, 12, and 18 months)
  • Difference in the proportion of patients with controlled BP between intervention and control groups(Measured from baseline to 18 months)
  • Penetrance (Providers)(Measured at baseline, 6, 12, and 18 months)
  • Sustainability Effectiveness Outcome: Difference in the proportion of patients with controlled BP(Measured at baseline and 24 months)
  • Side effects of medications and adverse events(Measured from baseline to 18 months)
  • Acceptability(Measured from baseline to 18 months)
  • Health Care Appointment Fidelity (community health worker-led strategy group)(Measured at 6, 12, and 18 months)
  • Sustainability of Fidelity(Measured at 24 months)
  • Exercise Session Fidelity (community health worker-led strategy group)(Measured at 6, 12, and 18 months)
  • Percentage of enrolled participants receiving assigned intervention. Measured by study administrative data. Reach (Participants)(Measured at baseline, 6, 12, and 18 months)
  • Reach (Participants)(Measured at baseline)
  • Penetrance (Participants)(Measured at baseline, 6, 12, and 18 months)
  • Sustainability (Participants)(Measured at 24 months)
  • Penetrance (educators)(Measured at baseline, 6, 12, and 18 months)
  • Sustainability (Churches)(Measured at baseline, 6, 12, and 18 months)
  • Sustainability Effectiveness Outcome: Differences in mean change of SBP and DBP(Measured at baseline and 24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jiang He, MD, PhD

Director Tulane University Translational Science Institute

Tulane University

研究点 (2)

Loading locations...

相似试验